Cargando…
WZB117 enhanced the anti-tumor effect of apatinib against melanoma via blocking STAT3/PKM2 axis
Background: Melanoma is the most lethal skin malignant tumor with a short survival once stepping into the metastatic status and poses a therapeutic challenge. Apatinib (a tyrosine kinase inhibitor) is a promising antiangiogenic agent for the treatment of metastatic melanoma. However, antiangiogenic...
Autores principales: | Zhang, Ren-Shu, Li, Zhi-Ke, Liu, Jie, Deng, Yao-Tiao, Jiang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524253/ https://www.ncbi.nlm.nih.gov/pubmed/36188586 http://dx.doi.org/10.3389/fphar.2022.976117 |
Ejemplares similares
-
The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells
por: Li, Yu-Liang, et al.
Publicado: (2019) -
WZB117 Decorated Metformin-Carboxymethyl Chitosan Nanoparticles for Targeting Breast Cancer Metabolism
por: De, Anindita, et al.
Publicado: (2023) -
The Biguanides Metformin and Buformin in Combination with 2-Deoxy-glucose or WZB-117 Inhibit the Viability of Highly Resistant Human Lung Cancer Cells
por: Yakisich, Juan Sebastian, et al.
Publicado: (2019) -
The $t \to WZb$ decay in the Standard Model: A Critical Reanalysis
por: Altarelli, Guido, et al.
Publicado: (2000) -
Trametinib Inhibits the Growth and Aerobic Glycolysis of Glioma Cells by Targeting the PKM2/c-Myc Axis
por: Gao, Mingjun, et al.
Publicado: (2021)